Newborn Cry Acoustics in the Assessment of Neonatal Opioid Withdrawal Syndrome Using Machine Learning
- PMID: 36301544
- PMCID: PMC9614579
- DOI: 10.1001/jamanetworkopen.2022.38783
Newborn Cry Acoustics in the Assessment of Neonatal Opioid Withdrawal Syndrome Using Machine Learning
Abstract
Importance: The assessment of opioid withdrawal in the neonate, or neonatal opioid withdrawal syndrome (NOWS), is problematic because current assessment methods are based on subjective observer ratings. Crying is a distinctive component of NOWS assessment tools and can be measured objectively using acoustic analysis.
Objective: To evaluate the feasibility of using newborn cry acoustics (acoustics referring to the physical properties of sound) as an objective biobehavioral marker of NOWS.
Design, setting, and participants: This prospective controlled cohort study assessed whether acoustic analysis of neonate cries could predict which infants would receive pharmacological treatment for NOWS. A total of 177 full-term neonates exposed and not exposed to opioids were recruited from Women & Infants Hospital of Rhode Island between August 8, 2016, and March 18, 2020. Cry recordings were processed for 118 neonates, and 65 neonates were included in the final analyses. Neonates exposed to opioids were monitored for signs of NOWS using the Finnegan Neonatal Abstinence Scoring Tool administered every 3 hours as part of a 5-day observation period during which audio was recorded continuously to capture crying. Crying of healthy neonates was recorded before hospital discharge during routine handling (eg, diaper changes).
Exposures: The primary exposure was prenatal opioid exposure as determined by maternal receipt of medication-assisted treatment with methadone or buprenorphine.
Main outcomes and measures: Neonates were stratified by prenatal opioid exposure and receipt of pharmacological treatment for NOWS before discharge from the hospital. In total, 775 hours of audio were collected and trimmed into 2.5 hours of usable cries, then acoustically analyzed (using 2 separate acoustic analyzers). Cross-validated supervised machine learning methods (combining the Boruta algorithm and a random forest classifier) were used to identify relevant acoustic parameters and predict pharmacological treatment for NOWS.
Results: Final analyses included 65 neonates (mean [SD] gestational age at birth, 36.6 [1.1] weeks; 36 [55.4%] female; 50 [76.9%] White) with usable cry recordings. Of those, 19 neonates received pharmacological treatment for NOWS, 7 neonates were exposed to opioids but did not receive pharmacological treatment for NOWS, and 39 healthy neonates were not exposed to opioids. The mean of the predictions of random forest classifiers predicted receipt of pharmacological treatment for NOWS with high diagnostic accuracy (area under the curve, 0.90 [95% CI, 0.83-0.98]; accuracy, 0.85 [95% CI, 0.74-0.92]; sensitivity, 0.89 [95% CI, 0.67-0.99]; specificity, 0.83 [95% CI, 0.69-0.92]).
Conclusions and relevance: In this study, newborn acoustic cry analysis had potential as an objective measure of opioid withdrawal. These findings suggest that acoustic cry analysis using machine learning could improve the assessment, diagnosis, and management of NOWS and facilitate standardized care for these infants.
Conflict of interest statement
Figures




Similar articles
-
Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns.JAMA Netw Open. 2022 Aug 1;5(8):e2228588. doi: 10.1001/jamanetworkopen.2022.28588. JAMA Netw Open. 2022. PMID: 36001312 Free PMC article.
-
Neonatal opioid toxicity: opioid withdrawal (abstinence) syndrome with emphasis on pharmacogenomics and respiratory depression.Arch Toxicol. 2023 Oct;97(10):2575-2585. doi: 10.1007/s00204-023-03563-8. Epub 2023 Aug 3. Arch Toxicol. 2023. PMID: 37537419 Review.
-
Comparison of neonatal outcomes in pregnant women undergoing medication-assisted treatment of opioid use disorder with methadone or buprenorphine/naloxone.J Matern Fetal Neonatal Med. 2022 Dec;35(26):10481-10486. doi: 10.1080/14767058.2022.2130238. Epub 2022 Oct 6. J Matern Fetal Neonatal Med. 2022. PMID: 36202398
-
Transplacental methadone exposure and risk of Neonatal Opioid Withdrawal Syndrome.Pharmacotherapy. 2024 Jan;44(1):22-27. doi: 10.1002/phar.2863. Epub 2023 Aug 23. Pharmacotherapy. 2024. PMID: 37574548
-
Clinical care of neonates undergoing opioid withdrawal in the immediate postpartum period.Neurotoxicol Teratol. 2021 Jul-Aug;86:106978. doi: 10.1016/j.ntt.2021.106978. Epub 2021 Apr 7. Neurotoxicol Teratol. 2021. PMID: 33838247 Review.
Cited by
-
Developmental toxicity: artificial intelligence-powered assessments.Trends Pharmacol Sci. 2025 Jun;46(6):486-502. doi: 10.1016/j.tips.2025.04.005. Epub 2025 May 15. Trends Pharmacol Sci. 2025. PMID: 40374415 Review.
-
The ultrasonic vocalization (USV) syllable profile during neonatal opioid withdrawal and a kappa opioid receptor component to increased USV emissions in female mice.bioRxiv [Preprint]. 2024 Sep 1:2024.07.02.601766. doi: 10.1101/2024.07.02.601766. bioRxiv. 2024. Update in: Psychopharmacology (Berl). 2025 Feb;242(2):427-447. doi: 10.1007/s00213-024-06694-7. PMID: 39005445 Free PMC article. Updated. Preprint.
-
Acoustic Cry Characteristics in Preterm Infants and Developmental and Behavioral Outcomes at 2 Years of Age.JAMA Netw Open. 2023 Feb 1;6(2):e2254151. doi: 10.1001/jamanetworkopen.2022.54151. JAMA Netw Open. 2023. PMID: 36723941 Free PMC article.
-
[An atrial fibrillation prediction model based on quantitative features of electrocardiogram during sinus rhythm in the Chinese population].Nan Fang Yi Ke Da Xue Xue Bao. 2025 Feb 20;45(2):223-228. doi: 10.12122/j.issn.1673-4254.2025.02.02. Nan Fang Yi Ke Da Xue Xue Bao. 2025. PMID: 40031965 Free PMC article. Chinese.
-
Neonatal Abstinence Signs during Treatment: Trajectory, Resurgence and Heterogeneity.Children (Basel). 2024 Feb 5;11(2):203. doi: 10.3390/children11020203. Children (Basel). 2024. PMID: 38397314 Free PMC article.
References
-
- Reddy UM, Davis JM, Ren Z, Greene MF; Opioid Use in Pregnancy, Neonatal Abstinence Syndrome, and Childhood Outcomes Workshop Invited Speakers . Opioid use in pregnancy, neonatal abstinence syndrome, and childhood outcomes: executive summary of a joint workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, American College of Obstetricians and Gynecologists, American Academy of Pediatrics, Society for Maternal-Fetal Medicine, Centers for Disease Control and Prevention, and the March of Dimes Foundation. Obstet Gynecol. 2017;130(1):10-28. doi:10.1097/AOG.0000000000002054 - DOI - PMC - PubMed